DK435276A - Fremgangsmade til fremstilling af prostaglandin-analoge og mellemprodukter til brug herved - Google Patents
Fremgangsmade til fremstilling af prostaglandin-analoge og mellemprodukter til brug hervedInfo
- Publication number
- DK435276A DK435276A DK435276A DK435276A DK435276A DK 435276 A DK435276 A DK 435276A DK 435276 A DK435276 A DK 435276A DK 435276 A DK435276 A DK 435276A DK 435276 A DK435276 A DK 435276A
- Authority
- DK
- Denmark
- Prior art keywords
- analoges
- prostaglandin
- procedure
- production
- intermediate products
- Prior art date
Links
- 239000013067 intermediate product Substances 0.000 title 1
- 150000003180 prostaglandins Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK163879A DK163879A (da) | 1975-09-29 | 1979-04-20 | 15-tetrahydropyranyloxyprostensyre-derivater til anvendelse som mellemprosukter ved fremstilling af prostaglandin-analoge |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/617,481 US4065472A (en) | 1975-09-29 | 1975-09-29 | 5-(2-Carboxythiophen-5-yl)-16-aryloxy-α-tetranor-ω-tetranorprostaglandins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK435276A true DK435276A (da) | 1977-03-30 |
Family
ID=24473823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK435276A DK435276A (da) | 1975-09-29 | 1976-09-28 | Fremgangsmade til fremstilling af prostaglandin-analoge og mellemprodukter til brug herved |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4065472A (en:Method) |
| JP (1) | JPS5242872A (en:Method) |
| BE (1) | BE846650A (en:Method) |
| CA (1) | CA1085832A (en:Method) |
| DE (1) | DE2640692C3 (en:Method) |
| DK (1) | DK435276A (en:Method) |
| FR (1) | FR2325371A1 (en:Method) |
| GB (1) | GB1508925A (en:Method) |
| IE (1) | IE44067B1 (en:Method) |
| LU (1) | LU75904A1 (en:Method) |
| NL (1) | NL7610761A (en:Method) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL95952A0 (en) * | 1989-10-19 | 1991-07-18 | Sterling Drug Inc | Aerosol composition for topical medicament |
| EP2217581B1 (en) * | 2007-11-09 | 2013-07-31 | Allergan, Inc. | Substituted cyclopentanes having prostaglandine activity |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1350971A (en) | 1971-05-11 | 1974-04-24 | Imp Chemi Als Ind Ltd | Cyclopentane derivatives |
| US3922289A (en) * | 1973-02-23 | 1975-11-25 | Syntex Inc | Trans-prostaglandin-like compounds and methods |
-
1975
- 1975-09-29 US US05/617,481 patent/US4065472A/en not_active Expired - Lifetime
-
1976
- 1976-07-30 IE IE1704/76A patent/IE44067B1/en unknown
- 1976-09-10 DE DE2640692A patent/DE2640692C3/de not_active Expired
- 1976-09-20 GB GB38949/76A patent/GB1508925A/en not_active Expired
- 1976-09-23 CA CA261,914A patent/CA1085832A/en not_active Expired
- 1976-09-28 BE BE1007651A patent/BE846650A/xx unknown
- 1976-09-28 DK DK435276A patent/DK435276A/da unknown
- 1976-09-29 FR FR7629245A patent/FR2325371A1/fr active Granted
- 1976-09-29 JP JP51117079A patent/JPS5242872A/ja active Granted
- 1976-09-29 NL NL7610761A patent/NL7610761A/xx not_active Application Discontinuation
- 1976-09-29 LU LU75904A patent/LU75904A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE2640692C3 (de) | 1979-09-13 |
| DE2640692A1 (de) | 1977-03-31 |
| CA1085832A (en) | 1980-09-16 |
| IE44067L (en) | 1977-03-29 |
| DE2640692B2 (en:Method) | 1979-01-18 |
| FR2325371A1 (fr) | 1977-04-22 |
| GB1508925A (en) | 1978-04-26 |
| NL7610761A (nl) | 1977-03-31 |
| IE44067B1 (en) | 1981-08-12 |
| FR2325371B1 (en:Method) | 1978-12-22 |
| LU75904A1 (en:Method) | 1977-05-11 |
| BE846650A (fr) | 1977-03-28 |
| JPS5242872A (en) | 1977-04-04 |
| US4065472A (en) | 1977-12-27 |
| JPS5437136B2 (en:Method) | 1979-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK455876A (da) | Fremgangsmade til fremstilling af 5-pyridinyl-2(1h)-pyridinoner og mellemprodukter herved | |
| DK449177A (da) | Fremgangsmaade til fremstilling af staal | |
| DK371276A (da) | Fremgangsmade til fremstilling af kautsjuk og middel til udovelse af fremgangsmaden | |
| DK76176A (da) | Fremgangsmade til fremstilling af 6,7-benzomorphanderivater og mellemprodukter herfor | |
| SE7600909L (sv) | Forfarande for framstellning av livsmedel | |
| IT1066078B (it) | Procedimento per la produzione di surrogati di albume | |
| DK554179A (da) | Fremgangsmaade til fremstilling af ergolinderivater | |
| SE7611091L (sv) | Forfarande for uppslutning av xylanhaltiga naturprodukter | |
| DK229476A (da) | Prostanderivater og fremgangsmade til fremstilling deraf | |
| SE426771B (sv) | Forfarande for kontinuerlig framstellning av ost | |
| IT1062629B (it) | Procedimento per la produzione di cantaxantina | |
| PL191647A1 (pl) | Sposob wytwarzania pochodnych tienopirydyny | |
| BG27355A3 (bg) | Метод за получаване на 11-дезокси-16-арилокси-w-тетранорпростагландини | |
| IT1064107B (it) | Procedimento per la produzione di nicotinammide | |
| DK147676A (da) | Fremgangsmade og anleg til kontinuerlig fremstilling af standardmelk | |
| BG27543A3 (bg) | Метод за получаване на n-арил-n-(1-l-4-пиперидинил)- арилацет-амиди | |
| IT1058100B (it) | Triisocianati biciclalifatici e procedimento per la loro froduzione ed applicazione | |
| DK490076A (da) | Fremgangsmade til fremstilling af 3-aminomethylen-6,7-dimethoxy-2-methyl-oxo1,2,3,4-tetrahydro-1-quinolin-carboxylsyre-estere og mellemprodukter herved | |
| AR208001A1 (es) | Procedimiento mejorado para la produccion de uroquinasa | |
| IT1061254B (it) | Procedimento per la produzione di policloroprene | |
| DK575576A (da) | Fremgangsmade til fremstilling af krystallinske former af natrium-cefamandol | |
| IT1052928B (it) | Procedimento per la produzione di floroglucina | |
| RO69281A (ro) | Procedeu pentru prepararea alchilamino-s-triazinelor | |
| DK559975A (da) | Fremgangsmade til fremstilling af 15-substituerede 11-desoxy-omega-pentanorprostaglandiner og mellemprodukter til anvendelse herved | |
| DK435276A (da) | Fremgangsmade til fremstilling af prostaglandin-analoge og mellemprodukter til brug herved |